Diffusion Pharmaceuticals...

NASDAQ: DFFN · Real-Time Price · USD
4.40
0.41 (10.28%)
At close: Aug 16, 2023, 10:00 PM

Diffusion Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
-18.23M -15.97M -24.68M
Interest Income
1.94M 380.75K 137.49K
Pretax Income
-16.29M -15.59M -24.54M
Net Income
-16.29M -15.21M -24.1M
Selling & General & Admin
9.17M 8.73M 7.45M
Research & Development
18.8M 7.24M 8.5M
Other Expenses
n/a n/a 93.42K
Operating Expenses
27.96M 15.97M 16.04M
Interest Expense
n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
n/a 15.97M 16.04M
Income Tax Expense
n/a -381K -444K
Shares Outstanding (Basic)
8.07M 2.04M 1.3M
Shares Outstanding (Diluted)
8.07M 1.36M 1.3M
EPS (Basic)
-2.02 -7.46 -18.57
EPS (Diluted)
-2.02 -11.19 -18.57
EBITDA
-18.23M -15.97M -7.31M
EBIT
n/a n/a n/a
Depreciation & Amortization
n/a -209K 93.42K